Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) encodes a homologue of the Epstein-Barr virus bZip protein EB1

Journal of General Virology

Volumn 80, Issue 3, 1999, Pages 557-561

  Gruffat, Henri ^a   Portes Sentis, Stéphanie ^a   Sergeant, Alain ^a   Manet, Evelyne ^a  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ARTICLE; EPSTEIN BARR VIRUS; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN HERPESVIRUS 8; INTRON; PRIORITY JOURNAL; RNA SPLICING; VIRUS GENOME;

EID: 0033028564     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-3-557     Document Type: Article

References (36)

1. Arvanitakis, L., Mesri, E. A., Nador, R. G., Said, J. W., Ash, A. S., Knowles, D. M. & Cesarman, E. (1996). Establishment and characterisation of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harbouring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) in the absence of Epstein-Barr virus. Blood 88, 2648-2654.
2. Buisson, M., Manet, E., Biemont, M. C., Gruffat, H., Durand, B. & Sergeant, A. (1989). The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R. Journal of Virology 63, 5276-5284.
3. Cesarman, E., Moore, P. S., Rao, P. H., Inghirami, G., Knowles, D. M. & Chang, Y. (1995). In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86, 2708-2714.
4. Chang, Y.-N., Dong, D. L-Y., Hayward, G. S. & Hayward, D. (1990). The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. Journal of Virology 64, 3358-3369.
5. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M. & Moore, P. S. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's Sarcoma. Science 266, 1865-1870.
6. Chavrier, P., Gruffat, H., Chevallier-Greco, A., Buisson, M. & Sergeant, A. (1989). The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the Epstein-Barr virus transactivator EB1 and an enhancer with constitutive and inducible activities. Journal of Virology 63, 607-614.
7. Chevallier-Greco, A., Manet, E., Chavrier, P., Mosnier, C., Daillie, J. & Sergeant, A. (1986). Both Epstein-Barr virus (EBV) encoded transacting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO Journal 5, 3243-3249.
8. Chevallier-Greco, A., Gruffat, H., Manet, E., Calender, A. & Sergeant, A. (1989). The EBV DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R. Journal of Virology 63, 615-623.
9. Countryman, J. & Miller, G. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proceedings of the National Academy of Sciences, USA 82, 4085-4089.
10. Cox, M. A., Leahy, J. & Hardwick, M. (1990). An enhancer within the divergent promoter of Epstein-Barr Virus responds synergically to the R and Z transactivators. Journal of Virology 64, 313-321.
11. Farrell, P. J., Rowe, D. T., Rooney, C. M. & Kouzarides, T. (1989). Epstein-Barr virus BZLF1 transactivator specifically binds to a consensus AP-1 site and is related to c-Fos. EMBO Journal 8, 127-132.
12. Fixman, E. D., Hayward, G. S. & Hayward, S. D. (1992). Trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. Journal of Virology 66, 5030-5039.
13. Flemington, E. & Speck, S. H. (1990a). Autoregulation of Epstein-Barr virus putative switch gene BZLF1. Journal of Virology 64, 1227-1232.
14. Flemington, E. & Speck, S. H. (1990b). Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues. Proceedings of the National Academy of Sciences, USA 87, 9459-9463.
15. Gaidano, G., Cechova, K., Chang, Y., Moore, P. S., Knowles, D. M. & Dalla-Favera, R. (1996). Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia 10, 1237-1240.
16. Giot, J.-F., Mikaelian, I., Buisson, M., Manet, E., Joab, I., Nicolas, J.-C. & Sergeant, A. (1991). Transcriptional interference between the EBV transcription factors EB1 and R: both the activation domain and the basic region are required. Nucleic Acids Research 19, 1251-1258.
17. Gruffat, H. & Sergeant, A. (1994). Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R. Nucleic Acids Research 22, 1172-1178.
18. Gruffat, H., Manet, E., Rigolet, A. & Sergeant, A. (1990). The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein. Nucleic Acids Research 18, 6835-6843.
19. Gruffat, H., Duran, N., Buisson, M., Wild, F., Buckland, R. & Sergeant, A. (1992). Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter. Journal of Virology 66, 46-52.
20. Holley-Guthrie, E. A., Quinlivan, E. B., Mar, E. B. & Kenney, S. (1990). The Epstein-Barr virus (EBV) BMRF1 promoter for the early antigen (EAD) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell specific manner. Journal of Virology 64, 3753-3759.
21. Kieff, E. (1996). Epstein-Barr virus and its replication. In Fields Virology, pp. 2343-2395. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
22. Kouzarides, T., Packham, G., Cook, A. & Farrell, P. J. (1991). The BZLF1 protein of the EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene 6, 195-204.
23. Lieberman, P. M., Hardwick, J. M., Sample, J., Hayward, G. S. & Hayward, S. D. (1990). The Zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. Journal of Virology 64, 1143-1155.
24. Manet, E., Gruffat, H., Trescol-Biemont, M.-C., Moreno, N., Chambard, P., Giot, J.-F. & Sergeant, A. (1989). Epstein-Barr virus bicistronic mRNA generated by facultative splicing code for two transcriptional transactivators. EMBO Journal 8, 1819-1826.
25. Miller, G., Rabson, M. & Heston, L. (1984). Epstein-Barr Virus with heterogeneous DNA disrupts latency. Journal of Virology 50, 174-182.
26. Miller, G., Heston, L., Grogan, E., Gradoville, L., Rigsby, M., Sun, R., Shedd, D., Kushnaryov, V. M., Grossberg, S. & Chang, Y. (1997). Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. Journal of Virology 71, 314-324.
27. Moore, P. S., Gao, S.-J., Dominguez, G., Cesarman, E., Lungu, O., Knowles, D. M., Garber, R., Pellett, P. E., McGeoch, D. J. & Chang, Y. (1996). Primary characterization of a herpesvirus agent asociated with Kaposi's sarcoma. Journal of Virology 70, 549-558.
28. Neipel, F., Albrecht, J.-C. & Fleckenstein, B. (1997). Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? Journal of Virology 71, 4187-4192.
29. Raab, M.-S., Albrecht, J.-C., Birkmann, A., Yaguboglu, S., Lang, D., Fleckenstein, B. & Neipel, F. (1998). The immunogenic glycoprotein gp35/37 of human herpesvirus 8 is encoded by open reading frame K8.1. Journal of Virology 72, 6725-6731.
30. Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D. & Ganem, D. (1996). Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Medicine 2, 342-346.
31. Rooney, C. M., Rowe, D. T., Ragot, T. & Farrell, P. J. (1989). The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. Journal of Virology 63, 3109-3116.
32. Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y. & Moore, P.S. (1996). Nucleotide sequence of the Kaposi sarcoma associated herpesvirus (HHV8). Proceedings of the National Academy of Sciences, USA 93, 14862-14867.
33. Schepers, A., Pich, D. & Hammerschmidt, W. (1993). A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO Journal 12, 3921-9.
34. Schulz, T. F. (1998). Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). Journal of General Virology 79, 1573-1591.
35. Sun, R., Lin, S.-F., Gradoville, L., Yuan, Y., Zhu, F. & Miller, G. (1998). A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proceedings of the National Academy of Sciences, USA 95, 10866-10871.
36. K) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO Journal 13, 5633-5638.